Search tips
Search criteria 


Logo of jepicomhJournal of Epidemiology and Community HealthVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Epidemiol Community Health. 1989 March; 43(1): 43–47.
PMCID: PMC1052789

The incidence of cancer in schizophrenic patients.


A cohort of 6168 schizophrenic patients was followed from 1957 to 1984 to determine the incidence of cancer in these patients. In the male schizophrenic patients the incidence of cancer was found to be significantly reduced in comparison with the general Danish population. This reduction was especially marked for cancer in the respiratory system, cancer of the prostate and cancer of the bladder. In the female patients the overall incidence of cancer did not differ from that of the general Danish population, but there was an increased risk of cancer of the digestive tract, especially cancer of the pancreas and a slight increase of the risk of breast cancer. In the female patients the risk of respiratory cancers and cancer of the female genital organs, especially cancer of the uterine cervix, was reduced. These alterations of the incidence of cancer in schizophrenic patients cannot be ascribed to differences in diagnostic accuracy. As a possible explanation of these findings a reduced exposure to well known carcinogens such as cigarette smoke may be relevant. We speculate that exposure to neuroleptics such as phenothiazines and reserpine may also be part of the explanation for the findings.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (755K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • du Pan RM, Müller C. La mortalité par cancer chez les patients psychiatriques hospitalisés. Schweiz Med Wochenschr. 1977 Apr 30;107(17):597–604. [PubMed]
  • Katz J, Kunofsky S, Patton RE, Allaway NC. Cancer mortality among patients in New York mental hospitals. Cancer. 1967 Dec;20(12):2194–2199. [PubMed]
  • Saugstad LF, Odegård O. Mortality in psychiatric hospitals in Norway 1950--74. Acta Psychiatr Scand. 1979 Apr;59(4):431–447. [PubMed]
  • Herrman HE, Baldwin JA, Christie D. A record-linkage study of mortality and general hospital discharge in patients diagnosed as schizophrenic. Psychol Med. 1983 Aug;13(3):581–593. [PubMed]
  • Andersen TF. Genanvendelse af historiske datamaterialer. Nogle erfaringer med reidentifikation af et tredive år gammelt materiale. Ugeskr Laeger. 1980 Apr 20;142(16):1054–1058. [PubMed]
  • Osterlind A, Jensen OM. Evaluering af cancerregistreringen i Danmark 1977. En praeliminaer evaluering af cancerregisterets og landspatientregisterets registrering af cancertilfaelde. Ugeskr Laeger. 1985 Jul 29;147(31):2483–2488. [PubMed]
  • HERRIDGE CF. Physical disorders in psychiatric illness. A study of 209 consecutive admissions. Lancet. 1960 Oct 29;2(7157):949–951. [PubMed]
  • Johnson DA. The evaluation of routine physical examination in psychiatric cases. Practitioner. 1968 May;200(199):686–691. [PubMed]
  • Hall RC, Popkin MK, Devaul RA, Faillace LA, Stickney SK. Physical illness presenting as psychiatric disease. Arch Gen Psychiatry. 1978 Nov;35(11):1315–1320. [PubMed]
  • Hall RC, Gardner ER, Popkin MK, Lecann AF, Stickney SK. Unrecognized physical illness prompting psychiatric admission: a prospective study. Am J Psychiatry. 1981 May;138(5):629–635. [PubMed]
  • Hall RC, Beresford TP, Gardner ER, Popkin MK. The medical care of psychiatric patients. Hosp Community Psychiatry. 1982 Jan;33(1):25–34. [PubMed]
  • Mortensen PB. Cancerdiagnostik og autopsifrekvens blandt skizofrene patienter. Ugeskr Laeger. 1987 Jul 13;149(29):1973–1975. [PubMed]
  • Masterson E, O'Shea B. Smoking and malignancy in schizophrenia. Br J Psychiatry. 1984 Oct;145:429–432. [PubMed]
  • Rotkin ID. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res. 1973 Jun;33(6):1353–1367. [PubMed]
  • Mortensen PB. Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients. Acta Psychiatr Scand. 1987 Jun;75(6):585–590. [PubMed]
  • Armstrong B, Stevens N, Doll R. Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. Lancet. 1974 Sep 21;2(7882):672–675. [PubMed]
  • Heinonen OP, Shapiro S, Tuominen L, Turunen MI. Reserpine use in relation to breast cancer. Lancet. 1974 Sep 21;2(7882):675–677. [PubMed]
  • Laska EM, Siegel C, Meisner M, Fischer S, Wanderling J. Matched-pairs study of reserpine use and breast cancer. Lancet. 1975 Aug 16;2(7929):296–300. [PubMed]
  • Mack TM, Henderson BE, Gerkins VR, Arthur M, Baptista J, Pike MC. Reserpine and breast cancer in a retirement community. N Engl J Med. 1975 Jun 26;292(26):1366–1371. [PubMed]
  • O'Fallon WM, Labarthe DR, Kurland LT. Rauwolfia derivatives and breast cancer. A case/control study in Olmsted County, Minnesota. Lancet. 1975 Aug 16;2(7929):292–296. [PubMed]
  • Schyve PM, Smithline F, Meltzer HY. Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue. Arch Gen Psychiatry. 1978 Nov;35(11):1291–1301. [PubMed]
  • Kanhouwa S, Gowdy JM, Solomon JD. Phenothiazines and breast cancer. J Natl Med Assoc. 1984 Aug;76(8):785–788. [PMC free article] [PubMed]
  • Pamukcu AM, Wattenberg LW, Price JM, Bryan GT. Phenothiazine inhibition of intestinal and urinary bladder tumors induced in rats by bracken fern. J Natl Cancer Inst. 1971 Jul;47(1):155–159. [PubMed]
  • Driscoll JS, Melnick NR, Quinn FR, Lomax N, Davignon JP, Ing R, Abott BJ, Congleton G, Dudeck L. Psychotropic drugs as potential antitumor agents: a selective screening study. Cancer Treat Rep. 1978 Jan;62(1):45–74. [PubMed]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Group